Literature DB >> 10805077

Immunolocalization of vascular endothelial growth factor in the GH3 cell line.

S Vidal1, M C Oliveira, K Kovacs, B W Scheithauer, R Lloyd.   

Abstract

The question of whether vascular endothelial growth factor (VEGF) is expressed in the GH3 cell line was investigated using immunocytochemistry, immunoelectron microscopy, and Western blotting. Using immunocytochemistry, VEGF was demonstrated in approximately 90% of the cells. Immunopositivity was localized mainly in the paranuclear Golgi region. In a small minority of cells, diffuse cytoplasmic immunostaining was also noted. By immunoelectron microscopy VEGF was evident in the secretory granules, cytoplasmic vesicles, rough endoplasmic reticulum, and the Golgi apparatus. Western blotting confirmed the results of the morphologic studies. It can be concluded that VEGF, which is know to induce angiogenesis and to increase vascular permeability, is produced in the prolactin- and growth hormone (GH)-secreting GH3 cell line. The functional role of VEGF in the GH3 cells is unknown. It is possible that this growth factor affects endocrine activity of GH3 cells by a paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805077     DOI: 10.1007/s004419900173

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 2.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Silvina Gutiérrez; Félix Daniel Roth; Agustín Aoki; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

4.  Methoxychlor-induced alterations in the histological expression of angiogenic factors in pituitary and uterus.

Authors:  Jerome M Goldman; Ashley S Murr; Angela R Buckalew; Judith E Schmid; Barbara D Abbott
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

5.  Myosin XVA expression in the pituitary and in other neuroendocrine tissues and tumors.

Authors:  R V Lloyd; S Vidal; L Jin; S Zhang; K Kovacs; E Horvath; B W Scheithauer; E T Boger; R A Fridell; T B Friedman
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF.

Authors:  Hidehisa Horiguchi; Long Jin; Katharina H Ruebel; Bernd W Scheithauer; Ricardo V Lloyd
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.